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Abstract
Background: Lower limb loss is a highly disabling medical condition that can severely impact a person’s quality of
life. Recovery becomes especially challenging if an amputee has a short residual limb, which can complicate proper
prosthetic fitting, causing discomfort, difficulties in suspension, and reduced mobility. Current limb lengthening
techniques such as the Ilizarov apparatus and external fixators are cumbersome, uncomfortable, and have high
complication rates. In this study, we investigated the effectiveness of a novel limb-lengthening device that uses
intramedullary bone lengthening and requires only one percutaneous rod at the end of the limb during the
distraction phase. Only the intramedullary nail remains after the distraction phase, and no external components are
required during the consolidation phase. We hypothesize that this system would create a much easier experience
for the patient.
Methods: The system was first tested in a mock surgical implantation using plastic femur bones. The device was
then tested in a series of cadaveric experiments using pelvis-to-knee specimens by a group of surgeons. Surgeons
evaluated the surgical insertion technique, soft tissue considerations, hardware fixation strategies, and the
effectiveness of the distraction mechanism. Revisions and improvements to the device and surgical procedure
were made based on the results from the cadaveric experiments.
Results: A questionnaire was given to two visiting surgeons following the final iteration of the device. The
surgeons reported that the system effectively lengthened the limb, was sturdy, and could be installed efficiently.
However, there remains a risk of infection and soft tissue imbalances, similar to that introduced by an external
fixator device. Suggestions on how to improve the design of the device and mitigate infection through
postoperative management and surgical standard of care will be considered for future clinical trials.
Conclusions: The described intramedullary residual limb-lengthening device has evolved from a prototype to a
mature model tested in six cadaveric experiments to date. Further mechanical and functional testing is needed to
finalize the device before testing in patients.
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Background
Limb loss is a devastating reality for millions of people
worldwide. In the USA alone, there are an estimated 1.6
million amputees, a number that is expected to increase
substantially by 2050 [1]. A significant number of these
amputations are due to trauma, including 1645 combat
injuries from the Iraq and Afghanistan wars that resulted
in major limb loss, or oncologic disease, in which the
exact amputation type and site are usually determined
by the level of injury or pathology [2, 3]. In these cases,
the residual limb length may be excessively short for
ideal prosthesis fitting and utilization.
A short residual limb can be especially distressing for
trauma or oncology patients, who are frequently young,
but otherwise healthy, and have the potential for signifi-
cant functional recovery through rehabilitation if fitted
with a well-functioning prosthetic device [2]. In the case
of excessively short transfemoral amputations (less than
35% of femoral length), it has been shown that a short
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residual limb can result in poor prosthetic fitting and
wear, difficulty with adductor muscle balancing, and
decreased hip strength. These complications combine to
result in increased wound complications, increased
energy consumption with ambulation, and decreased
mobility [2, 4–11]. In addition, power transfer to the
prosthesis is poor because the lever arm is short and
encased in soft, compliant thigh tissue, thus compromis-
ing control of the prosthesis. With short transfemoral
amputations, it is generally more preferable to lengthen
the residual limb rather than to convert to a higher level
of amputation given the major cosmetic and functional
restraints associated with hip disarticulation [12].
Most current limb and/or residual limb lengthening
methods rely on the process of distraction osteogenesis.
First, an osteotomy is made and a distracting force is ap-
plied, typically with an external fixation device that also
serves to stabilize the osteotomy site. After sufficient
elongation has occurred, the newly generated bone is
allowed to consolidate before removing the external
fixator. While distraction osteogenesis is an option to
improve skeletal deformities or treat complex fractures,
the technique requires a lengthy process that is
frequently associated with a number of complications,
including pin site infection, nonunion, and malunion.
Additionally, external fixation devices are generally
cumbersome and uncomfortable for patients, often
interfering with mobility, sleep, and the wearing of
clothing [2, 10, 12–21]. The devices are also bulky,
require 4–16 percutaneous wires or pins, and must be
worn for a minimum of 3 days per millimeter of additional
length (e.g., 300 days to gain 10 cm of length) [22].
Occasionally, an intramedullary device is used to aug-
ment lengthening and decrease the total time needed in
an external fixation device. This strategy has been shown
to have favorable results compared to external fixation-
only methods [13, 15, 17, 18, 23–25]. While newer intra-
medullary nail-only lengthening techniques have been
introduced for orthopedic surgeries, these are designed
primarily for intact limb lengthening [26–28].
To address the need for easier limb lengthening
systems in persons with above-knee amputation, our
team at Northwestern University and the Rehabilitation
Institute of Chicago (RIC) designed a novel residual
limb-lengthening device that uses intramedullary (IM)
bone lengthening and requires only one percutaneous
component during the distraction phase. With only one
distal percutaneous rod required and additional protect-
ive features designed to safely guide installation of the
device, we hypothesize that this system will be as effect-
ive in limb lengthening as current external techniques
but offer an easier, less burdensome option for patients,
specifically for persons with transfemoral (above-knee)
amputation.
Methods
The intramedullary (IM) lengthening device developed
over the course of this study consists of three main com-
ponents: an intramedullary (IM) nail, a threaded rod that
abuts the distal end of the IM nail, and an extension
tube with internal threading that fits over the IM nail/
threaded rod construct [Fig. 1a, b]. Additional features
include (i) a protective foam cover over the protruding
parts of the system to provide safety and increased com-
fort, (ii) a double o-ring seal within the tube to act as an
additional barrier and prevent bacteria from reaching
the IM nail, (iii) two anti-rotation keys constrained to
slide within a groove in the IM nail to prevent rotation
between the two bone segments, and (iv) a targeting
device to guide surgeons during the fixation process.
For device insertion, the patient is placed in a supine
position on a radiolucent table. Under C-arm guidance,
a 1–2-cm incision is made at the distal end of the
residual limb and blunt dissection is carried down to the
distal end of the femur. If needed, a larger distal incision
can be made to ensure that the muscular envelop of the
residual limb is properly protected and that sites for
myodesis are not damaged. Prior to performance of a
transverse osteotomy, the distal femoral canal is opened
(with an opening reamer if needed) and a stainless steel
dummy nail is driven into the intramedullary canal of
the femoral residual limb in a retrograde fashion. This
confirms that the intramedullary canal is wide enough
for proper insertion of the limb lengthener and provides
a durable stabilizing post during the osteotomy itself.
The osteotomy can be performed through a 2–3-cm
direct lateral approach to the femur with a Gigli saw
(passed around the femur with large right angle forceps
with both handles exiting through the lateral incision).
The osteotomy may then be completed if necessary with
an osteotome. After osteotomy, the assembled lengthen-
ing device can be inserted into the intramedullary canal
of the femoral residual limb in either an anterograde or
retrograde fashion, using targeting guides developed
specifically for the device (Fig. 2a, b).
The IM nail itself is fixed to the proximal bone seg-
ment with two interlocking screws (Stryker 1896-405OS)
using static guide holes fixed into the targeting guide.
The distal bone segment is attached to the extension
tube with two screws bilaterally (up to four total) also
using static guide holes fixed into the targeting guide.
Once in place, the threaded rod can be rotated against
the end of the fixed intramedullary nail to produce linear
distraction of the extension tube and the attached distal
bone segment (Figs. 3a, b and 4a–c). Notably, the
fixation screws placed in the extension tube (two screws
bilaterally) do not cross the entire construct. Instead,
they penetrate the femoral cortex and thread through
the near side of the extension tube before fixing
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themselves into an anti-rotation key. These keys (one
per side) fit into longitudinal grooves in the side of the
IM nail, allowing linear movement of the extension tube
with respect to the IM nail but not rotation.
Following implantation of the device, a handle is
attached to the distal end of the threaded rod. Rotation
of this handle rotates the threaded rod, producing pre-
dictable longitudinal distraction of the extension tube
and its attached bone segment with respect to the IM
nail. Once the residual limb has been sufficiently length-
ened, the handle, threaded rod, and extension tube may
be removed. The remaining intramedullary nail is
entirely contained in the limb.
In order to test the functionality of the installation
guide, the device was initially tested in a mock surgical
implantation using plastic femur bones. The device was
then tested in a series of cadaver experiments using
pelvis-to-knee specimens, in order to evaluate the surgi-
cal insertion techniques, how it interacted within the
soft tissues, hardware fixation strategies, and the effect-
iveness of the distraction mechanism. During each trial,
a prototype of the limb-lengthening device was im-
planted into a single cadaveric leg on which transfemoral
amputation had been performed to create a short
residual limb. In the first three sets of trials, a single
cadaver was used; in the fourth trial, three cadaveric
specimens were used. Refinements in the device were
made after each test, and the improved version was then
tested on a cadaveric specimen. Based on the outcomes
of each trial, the device and its targeting guide under-
went modifications and enhancements to improve the
ease of implantation and its overall effectiveness. Below,
we highlight important changes made to the device after
each trial.
Trial 1
 During insertion, the targeting device easily
detached from the nail, resulting in problems with
interlock targeting. We developed a stronger
clamping mechanism to maintain alignment
between the targeting device and limb lengthener.
 During drilling, the small screw holes in the
extension tube were easily occluded by bone chips
and soft tissue. We added a flat-tipped bottoming
drill and irrigation to clear these screw holes after
the initial drilling.
 We made the device thicker to increase its stiffness
and durability, which decreases the chance of poor
targeting of the drill sleeve during drilling.
Trial 2
 The proximal interlocking screws were reduced in
size from 5.0 to 4.0 mm (with a corresponding
Fig. 1 a Components of lengthening device disassembled. b Schematic of assembled lengthening device
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decrease in drill diameter from 4.2 to 3.5 mm)
to improve the ease of targeting/insertion.
 The drill size used for the distal screws was
increased to 5.0 from 4.2 mm to better uncover
the distal screw holes and clear them of bony/soft
tissue debris.
Trial 3
 It was noted that a Gigli saw could cut through the
aluminum dummy nail placed in the residual limb
during the osteotomy. The dummy nail was replaced
with a 440c stainless steel nail to increase its durability.
 Interchangeable arms were also added to the targeting
device to accommodate wider residual limbs.
Trial 4
 The gap between the proximal interlocking screws
for the intramedullary nail and the distal fixation
screws for the extension tube was decreased to allow
for use on shorter residual femoral limbs.
Fig. 2 a Targeting guide components. b Targeting guide schematic
(both anterograde and retrograde attachments shown)
Fig. 3 a Schematic of lengthening of residual limb using lengthening
device. b Schematic of lengthening of residual limb using
lengthening device
Fig. 4 a Lengthening device implanted in minimally invasive,
retrograde fashion into cadaveric specimen. b Demonstration of
successful distraction at osteotomy site using lengthening device
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Results
Insertion of the device into the cadaveric specimens took
approximately 15–20 min for each surgeon. An X-ray
image of the limb was taken to establish successful dis-
traction at the osteotomy site in the cadaveric specimen
using the lengthening device (Fig. 5). Following the trials,
two members of the surgical team (visiting surgeons) were
given a questionnaire to evaluate the device. They were
asked questions on ease of installation, rigidity and
strength of the device, and their impression of the design
of the system. They were also asked to comment on any
complications they anticipate during the patient’s use of
the device and to discuss any changes or additional
features they would like to see on the targeted device. All
visiting surgeons reported that they “strongly agreed” that
overall the limb lengthener was easy to install, was sturdy
and rigid enough, and seemed to be strong enough for its
intended use. The surgical team did not report any spe-
cific negative comments about device insertion. However,
in discussing anticipated problems for use in patients, two
major concerns arose that could occur during the distrac-
tion phase: (1) deep and superficial infections and (2) soft
tissue imbalances (varus deformity) created during length-
ening. These concerns are important to address with any
percutaneous device. The team advised that these issues
should be addressed through meticulous wound care and
additional soft tissue balancing procedures as needed (See
“Discussion”). Comments regarding potential complica-
tions during patient use of the device and desired add-
itional features will be taken into account for future
iterations of the device.
Discussion
Most current limb lengthening techniques employ
cumbersome devices and are fraught with high rates of
complications. Intramedullary nail lengthening techniques
with or without external fixator support have been shown
to increase patient comfort relative to traditional all-
external limb lengthening techniques [4, 10, 13, 15, 17,
23–25]. Currently available devices using these techniques
include the Albizzia nail, the ISKD® (Intramedullary Skel-
etal Kinetic Distractor) system (Orthofix Holdings, Inc.
Lewisville, TX), and the FITBONE® intramedullary nail
(WITTENSTEIN intens GmbH, Germany). These devices
have been shown to reduce time spent with an external
fixator (during the consolidation phase of lengthening), re-
duce rates of infection, and allow for faster rehabilitation
[26–28]. However, these systems are primarily designed
and used for lengthening intact limbs [17, 26, 27].
Amputation enables a very different and much easier
way to lengthen the residual limb long bone, as surgeons
can easily access the end of the bone. Yet, to our know-
ledge, there have been no devices designed specifically
for use as residual limb lengtheners. Most of the litera-
ture on the topic of residual limb lengthening comes
from case reports or small case series. These describe
either lengthening via distraction osteogenesis with an
external fixation device or with vascularized bone flaps
[6, 7, 10, 29–33]. Most authors have not only reported
high rates of soft tissue complications and infection but
also report reasonable improvements in prosthetic fitting
and function [6, 10, 32]. An alternate strategy was re-
ported recently by Henrichs et al., who replaced the en-
tire proximal femur with a modular endoprosthesis in 28
oncology patients to avoid hip disarticulation; however,
as with other strategies, this resulted in a relatively high
rate of infection and soft tissue complications [34]. Of
note, there is a recent case report by Paulsen et al.
describing residual limb lengthening over a nail. Their
group used the FITBONE® device, which is designed for
lengthening intact limbs, to lengthen a transfemoral am-
putation. It is unclear what, if any, modifications had to
be made to the device to allow for its use on a residual
limb [35].
This study documents the development of the first
known device designed specifically to lengthen transfe-
moral amputation residual limbs for the purpose of
improving prosthetic fitting, prosthesis comfort, and am-
bulation. The device (i) has only one distal percutaneous
component, (ii) allows accurate control of lengthening,
and (iii) stabilizes the residual bone during consolidation,
for earlier weight bearing. We hypothesize that compared
to external fixators, such a device could be less cumber-
some and possibly result in fewer complications for pa-
tients during the lengthening process. As noted above,
there is a report of residual limb lengthening using a
Fig. 5 Radiographic demonstration of successful distraction at
osteotomy site in cadaveric specimen using lengthening device
(note: only unilateral distal fixation screws are placed in this case)
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femoral lengthening nail (FITBONE®). Although this is a
potentially attractive option, at present, such a nail would
need to be custom ordered and likely manufactured on a
case-by-case basis. This is an expensive option that would
likely be an option only for patients with adequate insur-
ance coverage who are treated at a large medical center.
In comparison, our device is designed to be useful in a
wide-range of clinical scenarios. It is probable that the
simple construction of our device would allow for signifi-
cantly decreased cost compared to all internal nails (which
require somewhat complex mechanisms for lengthening).
At the very least, this device could serve as a useful
addition to a surgeon’s armamentarium for dealing with
short transfemoral residual limbs.
Early results in cadaveric models indicate that the de-
vice can be implanted quickly and easily by surgeons. Its
reliable targeting guide allows it to be placed in a min-
imally invasive fashion without the need for significant
fluoroscopy or substantial experience with the device.
Following implantation, the device provides consistent
lengthening with the use of its handle. Finally, the
lengthening components of the device are easily re-
moved, once again in a minimally invasive fashion with-
out a significant need for fluoroscopy, once sufficient
lengthening is achieved.
Though this device has been successfully implanted in ca-
daveric models, it is important to note that it has yet to be
tested on patients. Many aspects of the device’s in vivo per-
formance, such as lengthening ability, mechanical integrity,
local soft tissue response, and patient satisfaction can only
be predicted based on previous work with analogous limb
lengthening techniques [19, 24, 26–28]. There is a risk for
both superficial and deep tissue infections to be introduced
through the percutaneous attachment of the threaded rod/
handle, similar to current external fixator lengthening tech-
niques. Although the percutaneous attachment on our de-
vice is slightly larger than standard external fixator pins,
our device should not introduce further skin/wound de-
formation with longitudinal pin migration as is seen with
external fixator lengthening. Meticulous wound care at the
insertion site, and possibly, prophylactic antibiotics would
be needed to combat infection risk. If a clinically significant
infection were to occur, the device could be removed rela-
tively easily through its percutaneous attachment site (with
fluoroscopic guidance to remove crossing screws).
Additionally, soft tissue balancing may be challenging
during lengthening with this device, as it is with many
lengthening techniques. The surgeon should anticipate a
potential need for balancing procedures either at the
time of surgery or at a later date. The exact procedures
needed would have to be determined on an individualized
basis depending on preoperative residual limb length/mus-
cular attachments preserved, additional length desired,
and the technique used for their original amputation.
Finally, the threaded rod emerging from the distal end
of the residual limb could be an impediment during
mobilization and a general irritant to patients. Even so,
this single percutaneous element would likely be less
cumbersome to patients than an external fixator, espe-
cially a ringed fixator. Theoretically, a prosthesis could
even be designed with a small cutout to accommodate
the distal end of the threaded rod (the handle would
only need to be attached for rotation/lengthening).
Furthermore, after lengthening, the threaded rod is re-
moved, leaving only the IM rod in place during consoli-
dation. In contrast, an external fixator would need to
remain in place for the duration of the consolidation
phase to prevent fracture or deformity. Our limb-
lengthening device is currently undergoing approval test-
ing with the FDA and will undergo further modifications
as necessary before trials in patients begin.
Conclusions
The cadaveric experiments and subsequent design itera-
tions have led to a mature and functional device that has
been evaluated in six cadaveric specimens to date. Fur-
ther testing is needed in patients to determine if the de-
vice is safe, durable, and effective enough for its
intended use of lengthening transfemoral residual limbs.
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